Cervical radiculopathy
Cervical spondylosis of radiculopathy is also common. It is caused by unilateral or bilateral spinal nerve root stimulation or compression. It manifests as sensory, motor and reflex disorders consistent with the distribution area of the spinal nerve roots. The prognosis is generally good. Cervical spondylosis includes: cervical type cervical spondylosis, radiculopathy, spinal cord type cervical spondylosis, vertebral artery type cervical spondylosis, sympathetic nerve type cervical spondylosis, and esophageal compression type cervical spondylosis.
-
Site of disease:
Cervical spine peripheral nervous system -
Infectious :
Not contagious -
Frequent population:
Head-down workers, teachers, drivers -
Related symptoms:
Radiculopathy of cervical joints nerve root irritation sensory disturbance spinal nerve root damage neck pain
Related Drugs
Qige oral liquid
Manufacturer:
Jiangsu Kanion Pharmaceutical Co., Ltd.
Qige Granules
Manufacturer:
Jiangsu Kanion Pharmaceutical Co., Ltd.
Gujinwan Capsules
Manufacturer:
Heilongjiang Linhaixueyuan Pharmaceutical Co., Ltd.
Jingtong Granules
Manufacturer:
Sichuan Defeng Pharmaceutical Co., Ltd.
Bone Strengthening and Tendon Strengthening Capsules
Manufacturer:
Tonghua Golden-Horse Pharmaceutical Industey Co., Ltd.
Neck pain tablets
Manufacturer:
Shandong Mingren Freda Pharmaceutical Co., Ltd.
Anti-bone hyperplasia tablets
Manufacturer:
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
Cervical traction device
Indication: Suitable for traction of cervical spondylotic radiculopathy in hospitals.
Cervical vertebra treatment device
Indication: This product is suitable for the auxiliary treatment of cervical spondylosis, nerve root type cervical spondylosis, vertebral artery type cervical spondylosis, sympathetic cervical spondylosis, etc. Contraindications: The following patients are prohibited from using this product: pregnant women, menstruating women, patients with acute diseases, patients with malignant tumors, patients with severe heart disease, patients with skin perception disorders or skin abnormalities, patients wearing cardiac pacemakers, patients with built-in pacemakers, patients with fever, infants and young children, or those who cannot express their own will. For other precautions, please refer to the product manual.
Related Ingredients
-
Astragaloside IV list
83207-58-3 -
Riligustilide list
89354-45-0 -
MYRRH GUM list
9000-45-7 -
β-Cyclodextrin list
7585-39-9 -
Magnesium stearate list
557-04-0